Ribavirin. Red Book Committee recommendations questioned

We wrote this letter to comment on the recently published guidelines on the use of ribavirin for respiratory syncytial virus (RSV) infection,1 and to commend the commentary provided by Drs Wald and Dashefsky questioning these recommendations.2 In addition we point out the recent advertising campaign...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 1995-02, Vol.95 (2), p.319-319
Main Authors: Mitchell, I, Joffe, A, Newth, C J
Format: Article
Language:English
Subjects:
Child
Child, Preschool
Humans
Respiratory Syncytial Virus Infections - drug therapy
Ribavirin - adverse effects
Ribavirin - therapeutic use
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We wrote this letter to comment on the recently published guidelines on the use of ribavirin for respiratory syncytial virus (RSV) infection,1 and to commend the commentary provided by Drs Wald and Dashefsky questioning these recommendations.2 In addition we point out the recent advertising campaign by ICN Canada where it is claimed that the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) studies3,4 show "widespread underutilization" of ribavirin for RSV bronchiolitis,5 a conclusion not supported by detailed review of the literature.
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.95.2.319a